Clinical Trial Update: FAsenra Safety Trial in India [Phase 4]

View source ↗

Summary

Phase 4 safety trial of Fasenra (benralizumab) in adults with severe asthma with eosinophilic phenotype in India has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• FASENRA (BENRALIZUMAB)

Snippet

Sponsor: AstraZeneca | Conditions: In Adult Patients of Severe Asthma With Eosinophilic Phenotype in India | Phase 4 | Status: COMPLETED | Results posted: 2024-12-11